KG
Kathleen Goin (Chief Operating Officer) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Palvella Therapeutics, Inc. (PVLA). The largest single filing was $655K of PVLA (4,302 sh across 3 lots, as filed), executed Sep 16. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
12
0 buys · 12 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.0M
shares × price, as filed
Last traded
Oct 21
Filed Oct 23
Median ADV $37.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
12 filings
Sector per market data · by filing · past 12 months
Most traded names
PVLARecent filings
PVLASALE
Palvella Therapeutics, Inc.
View filing →
$461K3,706 sh across 2 lots
Exec Oct 21
Filed Oct 23 · 4:05 PM ET PVLASALE Palvella Therapeutics, Inc. View filing → $655K
4,302 sh across 3 lots
Exec Sep 16
Filed Sep 18 · 4:05 PM ET PVLASALE Palvella Therapeutics, Inc. View filing → $530K
3,498 sh across 2 lots
Exec Aug 19
Filed Aug 20 · 4:05 PM ET PVLASALE Palvella Therapeutics, Inc. View filing → $565K
3,780 sh across 3 lots
Exec Jul 15
Filed Jul 17 · 4:05 PM ET PVLASALE Palvella Therapeutics, Inc. View filing → $474K
4,277 sh across 2 lots
Exec Jun 17
Filed Jun 22 · 5:30 PM ET PVLASALE Palvella Therapeutics, Inc. View filing → $371K
3,363 sh × $110.35
Exec May 20
Filed May 22 · 5:30 PM ET PVLASALE Palvella Therapeutics, Inc. View filing → $380K
3,002 sh across 2 lots
Exec Apr 15
Filed Apr 17 · 5:30 PM ET PVLASALE Palvella Therapeutics, Inc. View filing → $471K
3,998 sh across 2 lots
Exec Mar 18
Filed Mar 20 · 5:30 PM ET More filings →